Nuclear Export of BRCA1 Occurs During Early S Phase and is Calcium-dependent

Overview

Journal Cell Signal

Date 2008 Feb 26

PMID 18296025

Citations 5

Authors

Katherine Glover-Collins

Marilyn E Thompson

Affiliations

Soon will be listed here.

Abstract

Although the breast cancer susceptibility gene 1 (BRCA1) protein is predominantly nuclear, its localization can vary during the cell cycle in response to cellular insults. For example, in S-phase cells, BRCA1 forms subnuclear foci and localizes to the perinuclear region in response to DNA damage. The present study provides evidence that BRCA1 is transiently excluded from the nucleus during the early part of S phase in the absence of DNA damage. The percentage of MCF-7 human breast cancer cells predominantly expressing nonnuclear BRCA1 significantly correlates with the percentage of cells within early S phase. This redistribution of BRCA1 is partially sensitive to leptomycin B, indicating that CRM-1-mediated nuclear export is involved. Similar results were observed with MCF-12A nonmalignant human mammary cells. The abilities of BAPTA-AM, an intracellular calcium chelator, to inhibit the change in BRCA1 localization, and of A23187, a calcium ionophore, and of thapsigargin to mimic nuclear exclusion of BRCA1, provide evidence for the involvement of calcium in this process. The calcium-mediated change in BRCA1 localization occurs in several cell lines, indicating that this effect is not cell line specific. BRCA2 localization is not affected by A23187. Furthermore, inhibition of calcium-calmodulin interaction and calcium-calmodulin dependent protein kinase II attenuates the calcium-mediated change in BRCA1 localization. These data suggest that BRCA1 nuclear export can be cell cycle-regulated by a calcium-dependent mechanism.

Citing Articles

Nesprin-2 mediated nuclear trafficking and its clinical implications.

Kelkar P, Walter A, Papadopoulos S, Mross C, Munck M, Peche V Nucleus. 2015; 6(6):479-89.

PMID: 26645154 PMC: 4915507. DOI: 10.1080/19491034.2015.1128608.

The emerging role of CaMKII in cancer.

Wang Y, Zhao R, Zhe H Oncotarget. 2015; 6(14):11725-34.

PMID: 25961153 PMC: 4494900. DOI: 10.18632/oncotarget.3955.

The BRCA1 Breast Cancer Suppressor: Regulation of Transport, Dynamics, and Function at Multiple Subcellular Locations.

Henderson B Scientifica (Cairo). 2013; 2012:796808.

PMID: 24278741 PMC: 3820561. DOI: 10.6064/2012/796808.

Kv3.4 potassium channel-mediated electrosignaling controls cell cycle and survival of irradiated leukemia cells.

Palme D, Misovic M, Schmid E, Klumpp D, Salih H, Rudner J Pflugers Arch. 2013; 465(8):1209-21.

PMID: 23443853 DOI: 10.1007/s00424-013-1249-5.

Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.

Gonzalez M, DuPrie M, Krueger H, Merajver S, Ventura A, Toy K Cancer Res. 2011; 71(6):2360-70.

PMID: 21406404 PMC: 3071296. DOI: 10.1158/0008-5472.CAN-10-1933.

References

Wilson C, Ramos L, Villasenor M, Anders K, Press M, Clarke K . Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet. 1999; 21(2):236-40. DOI: 10.1038/6029. View

Kahl C, Means A . Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev. 2003; 24(6):719-36. DOI: 10.1210/er.2003-0008. View

Zhu J, McKeon F . NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature. 1999; 398(6724):256-60. DOI: 10.1038/18473. View

Scully R, Chen J, Ochs R, Keegan K, Hoekstra M, Feunteun J . Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997; 90(3):425-35. DOI: 10.1016/s0092-8674(00)80503-6. View

Okada S, Ouchi T . Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization. J Biol Chem. 2002; 278(3):2015-20. DOI: 10.1074/jbc.M208685200. View

Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J . Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997; 88(2):265-75. DOI: 10.1016/s0092-8674(00)81847-4. View

Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie A . BRCA1 activation of the GADD45 promoter. Oncogene. 2000; 19(35):4050-7. DOI: 10.1038/sj.onc.1203759. View

Fitzgerald L, Bailey C, Brandt S, Thompson M . BRCA1 accumulates in the nucleus in response to hypoxia and TRAIL and enhances TRAIL-induced apoptosis in breast cancer cells. FEBS J. 2007; 274(19):5137-46. DOI: 10.1111/j.1742-4658.2007.06033.x. View

Rodriguez J, Henderson B . Identification of a functional nuclear export sequence in BRCA1. J Biol Chem. 2000; 275(49):38589-96. DOI: 10.1074/jbc.M003851200. View

10.

Chen C, Li S, Chen Y, Chen P, Sharp Z, Lee W . The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem. 1996; 271(51):32863-8. DOI: 10.1074/jbc.271.51.32863. View

11.

Moynahan M, Chiu J, Koller B, Jasin M . Brca1 controls homology-directed DNA repair. Mol Cell. 1999; 4(4):511-8. DOI: 10.1016/s1097-2765(00)80202-6. View

12.

Thompson M, Robinson-Benion C, Holt J . An amino-terminal motif functions as a second nuclear export sequence in BRCA1. J Biol Chem. 2005; 280(23):21854-7. DOI: 10.1074/jbc.M502676200. View

13.

Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y . The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem. 2001; 276(18):14537-40. DOI: 10.1074/jbc.C000881200. View

14.

Somasundaram K, Zeng Y, Houvras Y, Peng Y, Zhang H, Wu G . Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 1997; 389(6647):187-90. DOI: 10.1038/38291. View

15.

Chawla S, Vanhoutte P, Arnold F, Huang C, Bading H . Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem. 2003; 85(1):151-9. DOI: 10.1046/j.1471-4159.2003.01648.x. View

16.

Ruffner H, Verma I . BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci U S A. 1997; 94(14):7138-43. PMC: 23770. DOI: 10.1073/pnas.94.14.7138. View

17.

Xu X, Weaver Z, Linke S, Li C, Gotay J, Wang X . Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell. 1999; 3(3):389-95. DOI: 10.1016/s1097-2765(00)80466-9. View

18.

Gudas J, Li T, Nguyen H, Jensen D, Rauscher 3rd F, Cowan K . Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 1996; 7(6):717-23. View

19.

Bittinger M, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X . Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol. 2004; 14(23):2156-61. DOI: 10.1016/j.cub.2004.11.002. View

20.

Lotti L, Ottini L, DAmico C, Gradini R, Cama A, Belleudi F . Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer. 2002; 35(3):193-203. DOI: 10.1002/gcc.10105. View